Targeting antigenic site on RSV F protein associated with virus neutralization for vaccine design (#129)
Noushin Jaberolansar
1
,
Keith Chappell
1
2
,
Daniel Watterson
2
3
,
Sharareh Eskandari
1
,
Mariusz Skwarczynski
1
,
Paul Young
1
2
3
,
Istvan Toth
1
3
4
- School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, Australia
- Australian Infectious Diseases Research Centre, The University of Queensland, St Lucia , QLD, Australia
- Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, Australia
- School of Pharmacy, The University of Queensland, Woolloongabba , QLD, Australia
Publish consent withheld
- Bawage SS, Tiwari PM, Pillai S, Dennis V, Singh RS. (2013) AdvVir. 2013, 1-26.
- Kim HW, Canchola HG, Brandt CD, Pyles G, Chanock MR, Jense K, Parrott RH. (1969) Am J Epidemiol, 89: 422-434.
- Skwarczynski M, Zaman M, Toth I. (2013) In Handbook of the Biologically Active Peptides, ed Kastin A (Elsevier Burlington, Massachusetts), pp 571-579.
- Skwarczynski M, Toth I. (2014) Nanomedicine (Lond). 9(17):2657–2669.